Navigation Links
Bayer Announces Farnam Companies' Agreement to Halt Disputed Bio Spot® Ads
Date:6/17/2011

SHAWNEE, Kan., June 17, 2011 /PRNewswire/ -- Bayer HealthCare LLC announced today that it has reached a successful resolution of the lawsuit between Bayer and Farnam Companies Inc. over Farnam's advertising for its Bio Spot® flea and tick control products.  As part of the settlement, Farnam has agreed to withdraw the challenged advertising.

Farnam's print and online advertising campaign included claims that Bio Spot® was "as effective as popular vet brands," that Bio Spot® was "the best flea and tick control available," and that Bio Spot® was "the choice of professionals."  Farnam did not have any head-to-head clinical studies supporting its claims that its products were superior to, or as effective as, Bayer's premium flea and/or tick control products Advantage® II and K9 Advantix® II.  Bayer argued in a challenge submitted to the National Advertising Division of the Council of Better Business Bureaus (or NAD) that Farnam's advertising claims were false and unsubstantiated; Farnam responded by filing a lawsuit in the United States District Court for the District of Arizona seeking a declaration that its advertising was not false.

Today's settlement announcement ends both the NAD challenge and federal lawsuit.  As part of the settlement, Farnam has agreed to discontinue all of the advertising claims challenged by Bayer, and will refrain from making similar unsupported claims in future advertising.  Farnam will be given a short transition period to make the necessary changes to all of its advertising materials.

Bayer was represented by David H. Bernstein and Christopher Hamilton of Debevoise & Plimpton LLP, and Nicole Goodwin of Quarles & Brady LLP.

About Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR
'/>"/>

SOURCE Bayer HealthCare
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Bayers Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone
2. Bayers Discrimination Lawsuit Now Requires Extra-Strength Cure
3. Bayer to Present Data on Investigational Oncology Compounds at 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO)
4. Bayer HealthCare to Sponsor World Federation of Hemophilia Global Training Program and Donate Kogenate® FS, Antihemophilic Factor (Recombinant), Commercially Valued At More Than $7 Million
5. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion
6. Two New Studies in the British Medical Journal Find That Bayers Yaz and Yasmin Birth Control Pills Have an Increased Risk of Blood Clot
7. Bayer Launches First Interactive Virtual Walk in Support of Hemophilia
8. Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
9. Bayer HealthCare Selects the State of New Jersey for East Coast Site Consolidation
10. Bayer Gets $100M Gender Class Action Headache
11. TV Personality Vanessa Minnillo Teams Up With Bayer and March of Dimes to Launch National Folate Awareness Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty ... for the second quarter ended June 30, 2014. ... $6.5 million in the second quarter of 2014, an increase ... Total revenues of $13.3 million for the six months ended ... period in 2013 , Total revenues generated from the ...
(Date:7/24/2014)... ATLANTA , July 24, 2014  Alimera Sciences, ... company that specializes in the research, development and commercialization ... release its second quarter of fiscal year 2014 financial ... 2014. An investor conference call will follow on the ... The conference call will be hosted by Dan ...
(Date:7/24/2014)... BUFFALO, N.Y. , July 24, 2014  Kinex ... US FDA for the Company,s KX2-391 Ointment for the ... keratosis. This is the Company,s third IND to be ... months. KX2-391 is a synthetic, orally active ... and tubulin polymerization. KX2-391 promotes the induction of p53, ...
Breaking Medicine Technology:IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7Alimera Sciences To Release Second Quarter 2014 Results 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4
... Asthmatx, Inc. presented the results of a series ... thermoplasty delivered by the Alair® System, and how this ... in a poster at the 2009 Annual Meeting of ... in Miami Beach, Fla. , The poster, titled "Where ...
... PALO ALTO, Calif., Nov. 9 Women,s sexual health company, ... as it prepares for a 2010 launch of its Viveve ... a name that we believe captures the essence of our ... president and chief executive. "Viveve exists for the sole purpose ...
Cached Medicine Technology:Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 3Women's Sexual Health Company Changes Name in Preparation for Market Entry 2
(Date:7/25/2014)... (PRWEB) July 25, 2014 iTanSmart is ... and iPads. The app provides a tailored approach to ... potentially dangerous sunburns and skin damage. In his review, ... sounds, and capabilities of iTanSmart. , Eaton begins ... app as a ‘better organized’ and ‘great alternative’ to ...
(Date:7/25/2014)... According to the Liver Cirrhosis ... Vkool.com, this is a comprehensive guide that provides ... safe remedies for liver cirrhosis . This ...     Chapter 1: Liver Cirrhosis Bible & ... About Liver Basics ,     Chapter 3: Getting ...
(Date:7/25/2014)... July 25, 2014 At World T.E.A.M. ... July 19, 17 participating developmentally-disabled teens and young adults ... if off-road bicycling, canoeing and hiking can be challenging. ... at the scenic Chesapeake and Ohio Canal National ... athletes both disabled and able-bodied. Under slightly overcast skies ...
(Date:7/24/2014)... 2014 Dr. Henry H. Ting, a ... has been appointed senior vice president and chief quality ... his new role, he will oversee the hospital's clinical ... successfully led quality initiatives and interprofessional teams at the ... for the Door-to-Balloon Alliance, a collaboration of more than ...
(Date:7/24/2014)... bearing human breast tumors, exposure to dim light at ... drug tamoxifen, according to data published in Cancer ... Cancer Research. The negative effects of dim light exposure ... melatonin supplement during the night. , "Resistance to tamoxifen ... breast cancer," said Steven M. Hill, PhD, professor of ...
Breaking Medicine News(10 mins):Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 2Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 3Health News:Liver Cirrhosis Bible & Ezra Protocol Review Exposes Debra Elkin's Liver Cirrhosis Treatment Guide – Vkool - Better Information, Better Lives 2Health News:Liver Cirrhosis Bible & Ezra Protocol Review Exposes Debra Elkin's Liver Cirrhosis Treatment Guide – Vkool - Better Information, Better Lives 3Health News:DC Adventure Team Challenge Thrills Developmentally-Disabled Participants 2Health News:DC Adventure Team Challenge Thrills Developmentally-Disabled Participants 3Health News:NewYork-Presbyterian Hospital Names New Senior Vice President for Quality and Patient Safety 2Health News:NewYork-Presbyterian Hospital Names New Senior Vice President for Quality and Patient Safety 3Health News:Exposure to dim light at night may make breast cancers resistant to tamoxifen 2
... Jenifer Goodwin HealthDay Reporter , THURSDAY, Nov. ... known as "K2" is sending young people to the ... toxicologists warn. In recent months, physicians and toxicologists ... emergency rooms after smoking synthetic marijuana. Despite the side ...
... calculations in the supercomputer MareNostrum at the Barcelona Supercomputing ... for Research in Biomedicine (IRB Barcelona) have presented the ... this new database holds more than 1,700 proteins and ... has been developed to study the basic biology of ...
... Nov. 11 (HealthDay News) -- Long-term use of vitamin E ... in men, a new study finds. "An estimated 20.5 ... some evidence of age-related cataract," wrote study author William G. ... in Boston, and colleagues, in a news release. Because ...
... , THURSDAY, Nov. 11 (HealthDay News) -- Many U.S. ... dinner, meals that provide nutrients critical to youngsters, development, ... The American Dietetic Association Foundation poll of 1,193 ... found that breakfast is sometimes missed by 42 percent ...
... American Society of Nephrology (ASN) proudly highlight the ... The Halpin Foundation-ASN Research Grant, created to help ... provides recipients transition funding toward successful application for ... (McGill University Faculty of Medicine), the 2008 recipient ...
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, ... depicting emaciated lung cancer patients, a dead body in a ... of secondhand smoke) and other consequences of smoking that will ... people into quitting the habit or not starting in the ...
Cached Medicine News:Health News:'Fake Marijuana' Users Showing Up in Emergency Rooms 2Health News:'Fake Marijuana' Users Showing Up in Emergency Rooms 3Health News:Scientists at IRB Barcelona and BSC publish the world's largest video data bank of proteins 2Health News:Study Finds Vitamins E and C Don't Reduce Cataract Risk in Men 2Health News:Many Kids Skipping Meals, Snacking Instead 2Health News:Putting the spotlight on membranous nephropathy 2Health News:FDA Proposes Graphic Warnings on Cigarette Packs 2Health News:FDA Proposes Graphic Warnings on Cigarette Packs 3
... is a basic laboratory system for pH ... can be obtained when used with a ... • Fast and easy one and two-point ... five buffers (pH 1.68, 4.00, 7.00, 10.01 ...
... Multimode Detectors provide unmatched value and ... and automation needs. Capable of performing ... the same instrument, the DTX Series ... can be integrated seamlessly with Beckman ...
... is a dual-monochromator, multi-detection microplate reader ... 6-384 microplate reading capability. Detection modalities ... intensity (FI) and have optical performance ... or spectrophotometer. Endpoint, kinetic, spectrum and ...
... microplate reader combines improved flexibility ... with a wide range of ... the flexibility, sensitivity and high ... is the ideal detection solution ...
Medicine Products: